Clinical and Translational Oncology

, Volume 12, Issue 10, pp 647–649

The Nobel Prize in Physiology or Medicine 2009 “for telomere biology” and its relevance to cancer and related diseases



  1. 1.
    Müller HJ (1938) Bar duplication. Collecting Net (Woods Hole) 13:181–198Google Scholar
  2. 2.
    McClintock B (1939) The behavior in successive nuclear divisions of a chromosome broken at meiosis. Proc Natl Acad Sci U S A 25:405–416CrossRefPubMedGoogle Scholar
  3. 3.
    McClintock B (1941) The stability of broken ends of chromosomes in Zea mays. Genetics 28:234–282Google Scholar
  4. 4.
    Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains Exp Cell Res 25:585–621CrossRefGoogle Scholar
  5. 5.
    Watson JD (1972) Origin of concatemeric T7 DNA. Nat New Biol 239:197–201CrossRefPubMedGoogle Scholar
  6. 6.
    Olovnikov AM (1971) Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 201:1496–1499PubMedGoogle Scholar
  7. 7.
    Olovnikov AM (1973) A theory of marginotomy. The incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41:181–190CrossRefPubMedGoogle Scholar
  8. 8.
    Blackburn EH, Gall GJ (1978) A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120:33–53CrossRefPubMedGoogle Scholar
  9. 9.
    Szostak JW, Blackburn EH (1982) Cloning yeast telomeres on linear plasmid vectors. Cell 29:245–255CrossRefPubMedGoogle Scholar
  10. 10.
    Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405–413CrossRefPubMedGoogle Scholar
  11. 11.
    Greider CW, Blackburn EH (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51:887–898CrossRefPubMedGoogle Scholar
  12. 12.
    Lundblad V, Szostak JW (1989) A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57:633–643CrossRefPubMedGoogle Scholar
  13. 13.
    Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458–460CrossRefPubMedGoogle Scholar
  14. 14.
    Kim NW, Piatyszek MA, Prowse KR et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015CrossRefPubMedGoogle Scholar
  15. 15.
    Blasco MA, Lee HW, Hande MP et al (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25–34CrossRefPubMedGoogle Scholar
  16. 16.
    Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6:611–622CrossRefPubMedGoogle Scholar
  17. 17.
    Bryan TM, Reddel RR (1997) Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33:767–773CrossRefPubMedGoogle Scholar
  18. 18.
    Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70CrossRefPubMedGoogle Scholar
  19. 19.
    Deville L, Hillion J, Lanotte M et al (2006) Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias. Curr Pharm Biotechnol 7:171–183CrossRefPubMedGoogle Scholar
  20. 20.
    Pendino F, Tarkanyi I, Dudognon C et al (2006) Telomeres and telomerase: pharmacological targets for new anticancer strategies? Curr Cancer Drug Targets 6:147–180. ReviewCrossRefPubMedGoogle Scholar
  21. 21.
    Vonderheide RH (2008) Prospects and challenges of building a cancer vaccine targeting telomerase. Biochimie 90:173–180CrossRefPubMedGoogle Scholar
  22. 22.
    Mitchell JR, Wood E, Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551–555CrossRefPubMedGoogle Scholar
  23. 23.
    Mason PJ, Wilson DB, Bessler M (2005) Dyskeratosis congenita: a disease of dysfunctional telomere maintenance. Curr Mol Med 5:159–170CrossRefPubMedGoogle Scholar
  24. 24.
    Hills M, Lansdorp PM (2009) Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies Ann N Y Acad Sci 1176:178–190CrossRefPubMedGoogle Scholar
  25. 25.
    Kirwan M, Dokal I (2009) Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta 1792:371–379PubMedGoogle Scholar
  26. 26.
    Armanios MY, Chen JJ, Cogan JD et al (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356:1317–1326CrossRefPubMedGoogle Scholar
  27. 27.
    Alder JK, Chen JJ, Lancaster L et al (2008) Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 105: 13051–13056CrossRefPubMedGoogle Scholar
  28. 28.
    Valdes AM, Andrew T, Gardner JP et al (2005) Obesity, cigarette smoking, and telomere length in women. Lancet 366:662–664CrossRefPubMedGoogle Scholar
  29. 29.
    Epel ES, Blackburn EH, Lin J et al (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101:17312–17315CrossRefPubMedGoogle Scholar

Copyright information

© Feseo 2010

Authors and Affiliations

  1. 1.Instituto de Investigaciones Biomédicas CSIC/UAMMadridSpain
  2. 2.CIBER de Enfermedades Raras (CIBERER)ValenciaSpain

Personalised recommendations